Item 8.01. Other Events.

On October 27, 2021, Novavax, Inc. (the "Company") issued a press release announcing completion of its rolling regulatory submission to the U.K. Medicines and Healthcare products Regulatory Agency ("MHRA") for authorization of its COVID-19 vaccine candidate. A copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d)    Exhibits



Exhibit
  No.      Description

  99.1       Press release, dated October 27, 2021, regarding the Company's
           regulatory submission to the MHRA.

104        Cover Page Interactive Data File (formatted as Inline XBRL).

© Edgar Online, source Glimpses